Free Trial

Concentra Group Holdings Parent (CON) Competitors

Concentra Group Holdings Parent logo
$24.98 +0.23 (+0.94%)
Closing price 06/4/2026 03:59 PM Eastern
Extended Trading
$25.23 +0.25 (+1.00%)
As of 08:30 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CON vs. BTSG, FMS, HIMS, PACS, and CAI

Should you buy Concentra Group Holdings Parent stock or one of its competitors? MarketBeat compares Concentra Group Holdings Parent with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Concentra Group Holdings Parent include BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), Hims & Hers Health (HIMS), PACS Group (PACS), and Caris Life Sciences (CAI). These companies are all part of the "healthcare" industry.

How does Concentra Group Holdings Parent compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and Concentra Group Holdings Parent (NYSE:CON) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

Concentra Group Holdings Parent has a net margin of 7.97% compared to BrightSpring Health Services' net margin of 2.27%. Concentra Group Holdings Parent's return on equity of 47.14% beat BrightSpring Health Services' return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health Services2.27% 14.63% 4.41%
Concentra Group Holdings Parent 7.97%47.14%6.48%

In the previous week, BrightSpring Health Services and BrightSpring Health Services both had 5 articles in the media. BrightSpring Health Services' average media sentiment score of 1.15 beat Concentra Group Holdings Parent's score of 0.56 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Concentra Group Holdings Parent
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

BrightSpring Health Services has a beta of 1.87, meaning that its share price is 87% more volatile than the broader market. Comparatively, Concentra Group Holdings Parent has a beta of 0.82, meaning that its share price is 18% less volatile than the broader market.

BrightSpring Health Services presently has a consensus price target of $57.64, suggesting a potential upside of 0.42%. Concentra Group Holdings Parent has a consensus price target of $30.20, suggesting a potential upside of 20.88%. Given Concentra Group Holdings Parent's higher probable upside, analysts plainly believe Concentra Group Holdings Parent is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
15 Buy rating(s)
2 Strong Buy rating(s)
3.12
Concentra Group Holdings Parent
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86

BrightSpring Health Services has higher revenue and earnings than Concentra Group Holdings Parent. Concentra Group Holdings Parent is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$12.91B0.86$190.67M$1.4140.71
Concentra Group Holdings Parent$2.23B1.43$166.41M$1.3917.97

Summary

BrightSpring Health Services beats Concentra Group Holdings Parent on 9 of the 14 factors compared between the two stocks.

How does Concentra Group Holdings Parent compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Concentra Group Holdings Parent (NYSE:CON) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations, institutional ownership and media sentiment.

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 8.1% of Concentra Group Holdings Parent shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Fresenius Medical Care AG & Co. KGaA pays an annual dividend of $0.60 per share and has a dividend yield of 2.7%. Concentra Group Holdings Parent pays an annual dividend of $0.25 per share and has a dividend yield of 1.0%. Fresenius Medical Care AG & Co. KGaA pays out 31.6% of its earnings in the form of a dividend. Concentra Group Holdings Parent pays out 18.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Concentra Group Holdings Parent. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Concentra Group Holdings Parent, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA$19.36B0.61$1.11B$1.9011.53
Concentra Group Holdings Parent$2.23B1.43$166.41M$1.3917.97

Fresenius Medical Care AG & Co. KGaA has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market. Comparatively, Concentra Group Holdings Parent has a beta of 0.82, suggesting that its stock price is 18% less volatile than the broader market.

Concentra Group Holdings Parent has a net margin of 7.97% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.88%. Concentra Group Holdings Parent's return on equity of 47.14% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care AG & Co. KGaA4.88% 8.90% 4.05%
Concentra Group Holdings Parent 7.97%47.14%6.48%

In the previous week, Concentra Group Holdings Parent had 4 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 5 mentions for Concentra Group Holdings Parent and 1 mentions for Fresenius Medical Care AG & Co. KGaA. Concentra Group Holdings Parent's average media sentiment score of 0.56 beat Fresenius Medical Care AG & Co. KGaA's score of -0.67 indicating that Concentra Group Holdings Parent is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care AG & Co. KGaA
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Negative
Concentra Group Holdings Parent
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Fresenius Medical Care AG & Co. KGaA presently has a consensus target price of $28.00, indicating a potential upside of 27.77%. Concentra Group Holdings Parent has a consensus target price of $30.20, indicating a potential upside of 20.88%. Given Fresenius Medical Care AG & Co. KGaA's higher possible upside, research analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Concentra Group Holdings Parent.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.44
Concentra Group Holdings Parent
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86

Summary

Concentra Group Holdings Parent beats Fresenius Medical Care AG & Co. KGaA on 12 of the 18 factors compared between the two stocks.

How does Concentra Group Holdings Parent compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Concentra Group Holdings Parent (NYSE:CON) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation.

Concentra Group Holdings Parent has lower revenue, but higher earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Concentra Group Holdings Parent, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$2.35B2.77$128.37M-$0.09N/A
Concentra Group Holdings Parent$2.23B1.43$166.41M$1.3917.97

Hims & Hers Health currently has a consensus price target of $28.70, suggesting a potential upside of 2.21%. Concentra Group Holdings Parent has a consensus price target of $30.20, suggesting a potential upside of 20.88%. Given Concentra Group Holdings Parent's stronger consensus rating and higher probable upside, analysts clearly believe Concentra Group Holdings Parent is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
2 Sell rating(s)
11 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.12
Concentra Group Holdings Parent
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86

Hims & Hers Health has a beta of 2.37, suggesting that its stock price is 137% more volatile than the broader market. Comparatively, Concentra Group Holdings Parent has a beta of 0.82, suggesting that its stock price is 18% less volatile than the broader market.

In the previous week, Hims & Hers Health had 14 more articles in the media than Concentra Group Holdings Parent. MarketBeat recorded 19 mentions for Hims & Hers Health and 5 mentions for Concentra Group Holdings Parent. Hims & Hers Health's average media sentiment score of 0.84 beat Concentra Group Holdings Parent's score of 0.56 indicating that Hims & Hers Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
7 Very Positive mention(s)
6 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Concentra Group Holdings Parent
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Concentra Group Holdings Parent has a net margin of 7.97% compared to Hims & Hers Health's net margin of -0.56%. Concentra Group Holdings Parent's return on equity of 47.14% beat Hims & Hers Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health-0.56% 6.10% 1.52%
Concentra Group Holdings Parent 7.97%47.14%6.48%

63.5% of Hims & Hers Health shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by company insiders. Comparatively, 8.1% of Concentra Group Holdings Parent shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Concentra Group Holdings Parent beats Hims & Hers Health on 9 of the 16 factors compared between the two stocks.

How does Concentra Group Holdings Parent compare to PACS Group?

PACS Group (NYSE:PACS) and Concentra Group Holdings Parent (NYSE:CON) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, dividends, analyst recommendations, profitability and media sentiment.

PACS Group has higher revenue and earnings than Concentra Group Holdings Parent. Concentra Group Holdings Parent is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PACS Group$5.43B1.09$191.54M$1.5624.03
Concentra Group Holdings Parent$2.23B1.43$166.41M$1.3917.97

In the previous week, Concentra Group Holdings Parent had 4 more articles in the media than PACS Group. MarketBeat recorded 5 mentions for Concentra Group Holdings Parent and 1 mentions for PACS Group. Concentra Group Holdings Parent's average media sentiment score of 0.56 beat PACS Group's score of 0.00 indicating that Concentra Group Holdings Parent is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PACS Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Concentra Group Holdings Parent
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Concentra Group Holdings Parent has a net margin of 7.97% compared to PACS Group's net margin of 4.49%. Concentra Group Holdings Parent's return on equity of 47.14% beat PACS Group's return on equity.

Company Net Margins Return on Equity Return on Assets
PACS Group4.49% 26.47% 4.36%
Concentra Group Holdings Parent 7.97%47.14%6.48%

PACS Group presently has a consensus target price of $48.00, suggesting a potential upside of 28.05%. Concentra Group Holdings Parent has a consensus target price of $30.20, suggesting a potential upside of 20.88%. Given PACS Group's higher possible upside, research analysts plainly believe PACS Group is more favorable than Concentra Group Holdings Parent.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
Concentra Group Holdings Parent
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86

Summary

Concentra Group Holdings Parent beats PACS Group on 8 of the 13 factors compared between the two stocks.

How does Concentra Group Holdings Parent compare to Caris Life Sciences?

Caris Life Sciences (NASDAQ:CAI) and Concentra Group Holdings Parent (NYSE:CON) are both mid-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment.

Caris Life Sciences currently has a consensus price target of $27.56, suggesting a potential upside of 59.47%. Concentra Group Holdings Parent has a consensus price target of $30.20, suggesting a potential upside of 20.88%. Given Caris Life Sciences' higher possible upside, research analysts plainly believe Caris Life Sciences is more favorable than Concentra Group Holdings Parent.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Caris Life Sciences
1 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.45
Concentra Group Holdings Parent
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86

In the previous week, Concentra Group Holdings Parent had 2 more articles in the media than Caris Life Sciences. MarketBeat recorded 5 mentions for Concentra Group Holdings Parent and 3 mentions for Caris Life Sciences. Concentra Group Holdings Parent's average media sentiment score of 0.56 beat Caris Life Sciences' score of 0.40 indicating that Concentra Group Holdings Parent is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Caris Life Sciences
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Concentra Group Holdings Parent
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Concentra Group Holdings Parent has a net margin of 7.97% compared to Caris Life Sciences' net margin of 3.75%. Caris Life Sciences' return on equity of 98.28% beat Concentra Group Holdings Parent's return on equity.

Company Net Margins Return on Equity Return on Assets
Caris Life Sciences3.75% 98.28% 48.87%
Concentra Group Holdings Parent 7.97%47.14%6.48%

Concentra Group Holdings Parent has higher revenue and earnings than Caris Life Sciences. Caris Life Sciences is trading at a lower price-to-earnings ratio than Concentra Group Holdings Parent, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Caris Life Sciences$812.03M6.02-$68.09M-$7.61N/A
Concentra Group Holdings Parent$2.23B1.43$166.41M$1.3917.97

Summary

Concentra Group Holdings Parent beats Caris Life Sciences on 8 of the 12 factors compared between the two stocks.

Get Concentra Group Holdings Parent News Delivered to You Automatically

Sign up to receive the latest news and ratings for CON and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CON vs. The Competition

MetricConcentra Group Holdings ParentMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$3.17B$8.53B$6.30B$23.14B
Dividend Yield1.00%1.80%2.69%4.08%
P/E Ratio17.9722.9023.7431.05
Price / Sales1.4322.08498.0381.90
Price / Cash12.4088.3841.3924.44
Price / Book7.985.9210.044.72
Net Income$166.41M$178.24M$3.56B$1.07B
7 Day Performance0.53%-1.06%-1.04%-0.06%
1 Month Performance9.46%8.96%2.18%0.97%
1 Year Performance15.05%6.09%28.95%25.95%

Concentra Group Holdings Parent Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CON
Concentra Group Holdings Parent
4.5881 of 5 stars
$24.98
+0.9%
$30.20
+20.9%
+15.8%$3.17B$2.23B17.9713,133
BTSG
BrightSpring Health Services
4.1829 of 5 stars
$59.34
-1.1%
$57.00
-3.9%
+143.4%$11.51B$12.91B42.0923,500
FMS
Fresenius Medical Care AG & Co. KGaA
4.6507 of 5 stars
$20.56
-2.3%
$28.00
+36.2%
-22.4%$11.10B$19.36B10.821,488
HIMS
Hims & Hers Health
2.5938 of 5 stars
$27.51
-0.9%
$28.70
+4.3%
-47.8%$6.37B$2.37BN/A2,442
PACS
PACS Group
3.7448 of 5 stars
$36.82
+3.6%
$48.00
+30.4%
+268.9%$5.83B$5.43B23.6047,455

Related Companies and Tools


This page (NYSE:CON) was last updated on 6/5/2026 by MarketBeat.com Staff.
From Our Partners